Impact of diabetes on epidemiology, treatment, and outcomes of patients with heart failure

Cited by (400)

Items 101–200 of 400

1. Influence of Diabetes Mellitus on Outcomes in Patients After Left Ventricular Assist Device Implantation
   Chinenye O. Usoh, Saadia Sherazi, Barbara Szepietowska, Valentina Kutyifa, Scott A McNitt, Anna Papernov, Meng Wang, Jeffrey D. Alexis · 2018 · The Annals of Thoracic Surgery
2. Echocardiographic study of myocardial work in patients with type 2 diabetes mellitus
   Lisi Liao, Bobo Shi, Zhimin Ding, Lixin Chen, Fajin Dong, Jian Li, Yu Lin Zhong, Jinfeng Xu · 2022 · BMC Cardiovascular Disorders
3. GLP-1-ra and heart failure-related outcomes in patients with and without history of heart failure: an updated systematic review and meta-analysis
   Alessandro Villaschi, Giuseppe Ferrante, Francesco Cannata, Daniela Pini, Matteo Pagnesi, Elena Corrada, Bernhard Reimers, Roxana Mehran, Massimo Federici, Gianluigi Savarese et al. · 2024 · Clinical Research in Cardiology
4. Hyperglycaemia, Ejection Fraction and the Risk of Heart Failure or Cardiovascular Death in Patients with Type 2 Diabetes and a Recent Acute Coronary Syndrome
   Sung‐Hee Shin, Brian Lee Claggett, Marc Alan Pfeffer, Hicham Skali, Jiankang Liu, David A. Aguilar, Rafael Díaz, Kenneth Dickstein, Hertzel C. Gerstein, Lars Køber et al. · 2020 · European Journal of Heart Failure
5. Heart Failure, Diabetes Mellitus, and Chronic Kidney Disease
   David A. Aguilar · 2016 · Circulation Heart Failure
6. Platycodin D Ameliorates Type 2 Diabetes-Induced Myocardial Injury by Activating the AMPK Signaling Pathway
   Wenting Wang, Zi Wang, Zhaojie Meng, Shuang Jiang, Zhi Liu, Hongyan Zhu, Xin-dian Li, Jing Zhang, Wei Li · 2024 · Journal of Agricultural and Food Chemistry
7. Immunomodulation in Heart Failure with Preserved Ejection Fraction: Current State and Future Perspectives
   Elise L. Kessler, Marish I.F.J. Oerlemans, Patricia van den Hoogen, Carmen Yap, Joost P. G. Sluijter, Saskia C.A. de Jager · 2020 · Journal of Cardiovascular Translational Research
8. Chapter 1: The Burden of Heart Failure
   Richard E. Pratley, Xuan Guan, Richard J. Moro, Rodrigo do Lago · 2024 · The American Journal of Medicine
9. Heart Failure with Preserved Ejection Fraction: the Major Unmet Need in Cardiology
   Chi Young Shim · 2020 · Korean Circulation Journal
10. A Framework to Understand the Progression of Cardiovascular Disease for Type 2 Diabetes Mellitus Patients Using a Network Approach
    Md Ekramul Hossain, Shahadat Uddin, Arif M. Khan, Mohammad Ali Moni · 2020 · International Journal of Environmental Research and Public Health
11. Deep-learning-based prognostic modeling for incident heart failure in patients with diabetes using electronic health records: A retrospective cohort study
    Ilaria Gandin, Sebastiano Saccani, Andrea Coser, Arjuna Scagnetto, Chiara Cappelletto, Riccardo Candido, Giulia Barbati, Andrea Di Lenarda · 2023 · PLoS ONE
12. Antihyperglycemic Medication Use Among Medicare Beneficiaries With Heart Failure, Diabetes Mellitus, and Chronic Kidney Disease
    Priyesh Ashok Patel, Li Liang, Prateeti Khazanie, Bradley G. Hammill, Gregg C. Fonarow, Clyde W. Yancy, Deepak L. Bhatt, Lesley H. Curtis, Adrian F. Hernandez · 2016 · Circulation Heart Failure
13. 2018 consensus of the Taiwan Society of Cardiology and the Diabetes Association of Republic of China (Taiwan) on the pharmacological management of patients with type 2 diabetes and cardiovascular diseases
    Chern‐En Chiang, Shih-Yi Lin, Tsung‐Hsien Lin, Tzung‐Dau Wang, Hung‐I Yeh, Jung‐Fu Chen, Chia‐Ti Tsai, Yi-Jen Hung, Yi‐Heng Li, Ping‐Yen Liu et al. · 2018 · Journal of the Chinese Medical Association
14. Progressive right ventricular dysfunction and exercise impairment in patients with heart failure and diabetes mellitus: insights from the T.O.S.CA. Registry
    Andrea Salzano, Roberta D’Assante, Massimo Iacoviello, Vincenzo Triggiani, Giuseppe Rengo, Francesco Cacciatore, Ciro Maiello, Giuseppe Limongelli, Daniele Masarone, Angela Sciacqua et al. · 2022 · Cardiovascular Diabetology
15. Interrelationship between diabetes mellitus and heart failure: the role of peroxisome proliferator-activated receptors in left ventricle performance
    Evangelos K. Oikonomou, Konstantinos Mourouzis, Petros N. Fountoulakis, George-Angelo Papamikroulis, Gerasimos Siasos, Alexios S. Antonopoulos, Georgia Vogiatzi, Sotiris Tsalamadris, Manolis Vavuranakis, Dimitris Tousoulis · 2018 · Heart Failure Reviews
16. Predictors of heart failure development in type 2 diabetes
    Subodh Verma, Abhinav Sharma, Naresh Kanumilli, Javed Butler · 2019 · Current Opinion in Cardiology
17. Mechanisms and Perspectives of Sodium-Glucose Co-transporter 2 Inhibitors in Heart Failure
    Qingchun Zeng, Qing Zhou, Weitao Liu, Yutong Wang, Xingbo Xu, Dingli Xu · 2021 · Frontiers in Cardiovascular Medicine
18. Role of continuous glucose monitoring in diabetic patients at high cardiovascular risk: an expert-based multidisciplinary Delphi consensus
    Carlo Di Mario, Stefano Genovese, Gaetano Antonio Lanza, Edoardo Mannucci, Giancarlo Marenzi, Edoardo Sciatti, Dario Pitocco, the Expert Panel Group, Angelo Avogaro, Federico Bertuzzi et al. · 2022 · Cardiovascular Diabetology
19. Long-term outcomes for heart failure patients with and without diabetes: From the Get With The Guidelines–Heart Failure Registry
    Boback Ziaeian, Adrian F. Hernandez, Adam D. DeVore, Jingjing Wu, Haolin Xu, Paul A. Heidenreich, Roland Matsouaka, Deepak L. Bhatt, Clyde W. Yancy, Gregg C. Fonarow · 2019 · American Heart Journal
20. Serum Individual Nonesterified Fatty Acids and Risk of Heart Failure in Older Adults
    Luc Djoussé, Mary Lou Biggs, Nirupa Rachel Matthan, Joachim H. Ix, Annette L. Fitzpatrick, Irena B. King, Rozenn N. Lemaître, Barbara McKnight, Jorge R. Kizer, Alice Hinda Lichtenstein et al. · 2021 · Cardiology
21. Sodium-Glucose Cotransporter 2 Inhibitors and Heart Failure: A Bedside-to-Bench Journey
    Donato Cappetta, Antonella De Angelis, Gabriella Bellocchio, Marialucia Telesca, Eleonora Cianflone, Daniele Torella, Francesco Rossi, Konrad Urbanek, Liberato Berrino · 2021 · Frontiers in Cardiovascular Medicine
22. Is the Use of DPP-4 Inhibitors Associated With an Increased Risk for Heart Failure? Lessons From EXAMINE, SAVOR-TIMI 53, and TECOS
    Guntram Schernthaner, Avivit Cahn, Itamar Raz · 2016 · Diabetes Care
23. Therapeutic strategies targeting mechanisms of macrophages in diabetic heart disease
    Chaoyue Zhang, Yunke Shi, Changzhi Liu, Shivon Mirza Sudesh, Hu Zhao, Pengyang Li, Qi Liu, Yiming Ma, Ao Shi, Hongyan Cai · 2024 · Cardiovascular Diabetology
24. The Use of SGLT-2 Inhibitors in Type 2 Diabetes and Heart Failure
    Kayla A. Riggs, Hiba Ali, Heinrich Taegtmeyer, Absalon Gutierrez · 2015 · Metabolic Syndrome and Related Disorders
25. Cardiac Structure and Function and Diabetes‐Related Risk of Death or Heart Failure in Older Adults
    Riccardo Maria Inciardi, Brian Lee Claggett, Deepak K. Gupta, Susan C. Cheng, Jiankang Liu, Justin B. Echouffo Tcheugui, Chiadi Ndumele, Kunihiro Matsushita, Elizabeth Selvin, Scott David Solomon et al. · 2022 · Journal of the American Heart Association
26. Role of Primary Care Clinicians in the Management of Patients With Type 2 Diabetes and Cardiorenal Diseases
    Pamela R. Kushner, Matthew Aaron Cavender, Christian W. Mende · 2022 · Clinical Diabetes
27. Evolution of Mineralocorticoid Receptor Antagonists in the Treatment of Chronic Kidney Disease Associated with Type 2 Diabetes Mellitus
    Jay B. Wish, Pablo E. Pérgola · 2022 · Mayo Clinic Proceedings Innovations Quality & Outcomes
28. Heart Failure and Diabetes Mellitus: Dangerous Liaisons
    Hae‐Young Lee · 2022 · International Journal of Heart Failure
29. Circulating Brain-Derived Neurotrophic Factor Levels and Heart Failure: A Systematic Review and Meta-Analysis
    Amir Hossein Behnoush, Amirmohammad Khalaji, Andarz Fazlollahpour Naghibi, K H Bagheri, Parmis Goshtasbi, Ghazal Mohseni, Aouatif Erasmia El Kanty, Caterina Vinciguerra, Alessandro Cannavò · 2024 · ESC Heart Failure
30. The association of comorbid diabetes mellitus and symptoms of depression with all-cause mortality and cardiac rehospitalization in patients with heart failure
    Geri C. Reeves, Abdullah S. Alhurani, Susan K. Frazier, John F. Watkins, Terry A. Lennie, Debra Kay Moser · 2015 · BMJ Open Diabetes Research & Care
31. Metformin: Up to Date
    Silvia Maria Sciannimanico, Franco Grimaldi, Fabio Vescini, Giovanni De Pergola, Massimo Iacoviello, Brunella Licchelli, Edoardo Guastamacchia, Vito Angelo Giagulli, Vincenzo Triggiani · 2019 · Endocrine Metabolic & Immune Disorders - Drug Targets
32. Management of heart failure and type 2 diabetes mellitus: Maximizing complementary drug therapy
    Javed Butler, James L. Januzzi, Julio Rosenstock · 2020 · Diabetes Obesity and Metabolism
33. Relationship between skin autofluorescence levels and clinical events in patients with heart failure undergoing cardiac rehabilitation
    Mitsuhiro Kunimoto, Miho Nishitani Yokoyama, Kazunori Shimada, Tomomi Matsubara, Tatsuro Aikawa, Shohei Ouchi, Kosuke Fukao, Tetsuro Miyazaki, Kei Fujiwara, Abidan Abulimiti et al. · 2021 · Cardiovascular Diabetology
34. Effects of diabetes mellitus on left ventricular function and remodeling in hypertensive patients with heart failure with reduced ejection fraction: assessment with 3.0 T MRI feature tracking
    Ge Zhang, Ke Shi, Wei‐Feng Yan, Xue‐Ming Li, Yuan Li, Yingkun Guo, Zhi‐gang Yang · 2022 · Cardiovascular Diabetology
35. Evidence of a bi-directional relationship between heart failure and diabetes: a strategy for the detection of glucose abnormalities and diabetes prevention in patients with heart failure
    Paul Elie Valensi · 2024 · Cardiovascular Diabetology
36. The role of estrogen in the sex difference for the risk factors of heart failure with preserved ejection fraction
    Jun Du, Jiaqi Liu, Xiaowu Wang, Xiaowu Wang, Yu Ma, Sipan Zhang, Zilin Li, Jipeng Ma, Jincheng Liu · 2025 · Biology Direct
37. DPP-4 inhibitors, heart failure and type 2 diabetes: all eyes on safety.
    Francesco Paneni · 2015 · PubMed Central
38. The role of sodium glucose cotransporter-2 (SGLT-2) inhibitors in heart failure and chronic kidney disease in type 2 diabetes
    Vincent C. Woo, Kim Alexander Connelly, Peter Lin, Philip A. McFarlane · 2019 · Current Medical Research and Opinion
39. Association Between Metabolic Syndrome and an Increased Risk of Hospitalization for Heart Failure in Population of HFpEF
    Ying Zhou, Liyao Fu, Jiaxing Sun, Zhaowei Zhu, Zhenhua Xing, Shenghua Zhou, Shi Tai, Yongjun Wang · 2021 · Frontiers in Cardiovascular Medicine
40. Novel insight into the dangerous connection between diabetes and heart failure
    Carlo Lombardi, Valentina Spigoni, Elio Gorga, Alessandra Dei · 2016 · Herz
41. Long-term LVEF trajectories in patients with type 2 diabetes and heart failure: diabetic cardiomyopathy may underlie functional decline
    María Teresa Julián, Núria Alonso, Josep Lupón, Giovana Gavidia‐Bovadilla, Elena Ferrer, Marta de Antonio, Jorge López‐Ayerbe, Mar Domingo, Evelyn Santiago‐Vacas, Elisabet Zamora et al. · 2020 · Cardiovascular Diabetology
42. Consenso de expertos sobre la insuficiencia cardiaca con fracción de eyección reducida: más allá de las guías
    Manuel P. Anguita, Antoni Bayés‐Genís, José María Cepeda, Sergio Cinza‐Sanjurjo, Juan Cosín, Marisa Crespo Leiro, Isabel Egocheaga, Carlos Escobar, Mercè Faraudo, José María García-Pinilla et al. · 2020 · Revista Española de Cardiología Suplementos
43. Imaging techniques for the assessment of adverse cardiac remodeling in metabolic syndrome
    Alberto Preda, Luca Liberale, Fabrizio Montecucco · 2021 · Heart Failure Reviews
44. Glucose-lowering drugs and heart failure: implications of recent cardiovascular outcome trials in type 2 diabetes
    Gaia Cattadori, Paola Pantanetti, Giuseppe Ambrosio · 2019 · Diabetes Research and Clinical Practice
45. Insulin Withdrawal in Diabetic Kidney Disease: What Are We Waiting for?
    Carlos Morillas, Luis D’Marco, María Jesús Puchades, Eva Solá-Izquierdo, C. Górriz-Zambrano, Valmore Bermúdez, José Luis Górriz · 2021 · International Journal of Environmental Research and Public Health
46. Metformin: Expanding the Scope of Application—Starting Earlier than Yesterday, Canceling Later
    Yulia A. Kononova, Nikolai P. Likhonosov, Alina Yu. Babenko · 2022 · International Journal of Molecular Sciences
47. Efficacy and safety of mineralocorticoid receptor antagonists for patients with heart failure and diabetes mellitus: a systematic review and meta-analysis
    Mengdie Chen, Sisi Dong, Ningyu Cai, Mengdi Fan, Su-Ping Gu, Jin-Jue Zheng, Haimin Yin, Xinhe Zhou, Liang-Xue Wang, Chunying Li et al. · 2016 · BMC Cardiovascular Disorders
48. Early and Chronic Dipeptidyl‐Peptidase‐IV Inhibition and Cardiovascular Events in Patients With Type 2 Diabetes Mellitus After an Acute Coronary Syndrome: A Landmark Analysis of the EXAMINE Trial
    Abhinav Sharma, Christopher Paul Cannon, William B. White, Yuyin Liu, George L. Bakris, William C. Cushman, Faiez M. Zannad · 2018 · Journal of the American Heart Association
49. Incidence of heart failure in patients with type 1 diabetes: a systematic review of observational studies
    Angelo Avogaro, Danila Azzolina, Gian Paolo Fadini, Ileana Baldi · 2020 · Journal of Endocrinological Investigation
50. Heart Failure
    Audrey H. Wu · 2018 · Annals of Internal Medicine
51. NT-proBNP values in elderly heart failure patients with atrial fibrillation and diabetes
    Adela Viviana Sitar Tǎut, Dana Pop, Dumitru Tudor Zdrenghea · 2015 · Journal of Diabetes and its Complications
52. Cardiovascular and renal disease manifestation and healthcare resource utilization in patients on first‐line oral therapy for type 2 diabetes: A claims‐based observational cohort study
    Temitope O. Olufade, Like Jiang, Rubeen Israni, Joanna Huang, Aidar R. Gosmanov · 2021 · Diabetes Obesity and Metabolism
53. Reduced Exercise Capacity in Diabetes Mellitus Is Not Associated with Impaired Deformation or Twist
    Timothy J. Roberts, James F. Barros-Murphy, Andrew Burns, Richard J. MacIsaac, Andrew I. MacIsaac, David Prior, André La Gerche · 2020 · Journal of the American Society of Echocardiography
54. Type 2 diabetes: A protective factor for COPD?
    Louise H. Rayner, Andrew Peter McGovern, Julian Sherlock, Piers A.C. Gatenby, Ana Correa, Ben C. Creagh-Brown, Simon de Lusignan · 2018 · Primary care diabetes
55. Combination of ST2 and B-type natriuretic peptide in diabetic patients with acute heart failure: relation with ventricular stiffness and outcome
    Gaetano M. Ruocco, Isabella Evangelista, Beatrice Franci, Barbara Lucani, Simona Martini, Ranuccio Nuti, Alberto Palazzuoli · 2018 · Journal of Cardiovascular Medicine
56. Dysthyroidism and Chronic Heart Failure: Pathophysiological Mechanisms and Therapeutic Approaches
    Caterina Rizzo, Margherita Ilaria Gioia, Giuseppe Parisi, Vincenzo Triggiani, Massimo Iacoviello · 2017 · Advances in experimental medicine and biology
57. Perspective Review : Type 2 Diabetes and Readmission for Heart Failure
    Merlin C. Thomas · 2018 · Clinical Medicine Insights Cardiology
58. Epidemiology, Diagnosis, Pathophysiology, and Initial Approach to Heart Failure with Preserved Ejection Fraction
    Theresa Anderson, Scott L. Hummel, Matthew C. Konerman · 2022 · Cardiology Clinics
59. Efficacy of SGLT2 inhibitors for anthracycline-induced cardiotoxicity: a meta-analysis in cancer patients
    Sana Mohsin, Misha Hasan, Zubaid Moazzam Sheikh, Fatima Mustafa, Vesna Tegeltija, Sarwan Kumar, Jai Kumar · 2024 · Future Cardiology
60. The emerging role of novel antihyperglycemic agents in the treatment of heart failure and diabetes: A focus on cardiorenal outcomes
    Kelly R. McHugh, Adam D. DeVore, Robert John Mentz, Daniel L. Edmonston, Jennifer B. Green, Adrian F. Hernandez · 2018 · Clinical Cardiology
61. Diabetes Mellitus Is Not a Risk Factor for Patients Supported With Left Ventricular Assist Device
    Pengyu Zhou, Zezhou Xiao, Peng Zhu, Zhiqiang Nie, Desai Pavan, Shaoyi Zheng · 2019 · The Annals of Thoracic Surgery
62. Prevalence, prescriptions, outcomes and costs of type 2 diabetes patients with or without prior coronary artery disease or stroke: a longitudinal 5-year claims-data analysis of over 7 million inhabitants
    Aldo Pietro Maggioni, Letizia Dondi, Felicita Andreotti, Giulia Ronconi, Silvia Calabria, Carlo Pasquale Piccinni, Antonella Pedrini, Imma Esposito, Nello Martini · 2021 · Therapeutic Advances in Chronic Disease
63. Traditional Ethnobotanical Knowledge on Medicinal Plants Used by the Populations in Central Russikada (Northeastern Algeria)
    Nabila Souilah, Mohamed Djamel Mıara, Hamdi Bendıf, Kamel Medjroubi, Julie Snorek · 2021 · Journal of Herbs Spices & Medicinal Plants
64. Type 2 Diabetes Mellitus and Heart Failure: Innovative Possibilities for Management of Prognosis
    Zhanna D. Kobalava, N. V. Yeshniyazov, Vadim Medovchshikov, Э. Р. Хасанова · 2019 · Kardiologiia
65. The “discordant doppelganger dilemma”: SGLT2i mimics therapeutic carbohydrate restriction - food choice first over pharma?
    Scott W. Murray, Sean McKelvey, Thomas Heseltine, George Henderson, Jagdeep S. Singh, David Unwin, Adrian J B Brady · 2021 · Journal of Human Hypertension
66. The complex interplay between diabetes mellitus and atrial fibrillation
    Mehmet Yildiz, Carl J. Lavie, Daniel P. Morin, Ahmet Afşin Oktay · 2022 · Expert Review of Cardiovascular Therapy
67. Derivation and External Validation of a Clinical Model to Predict Heart Failure Onset in Patients With Incident Diabetes
    Louise Y. Sun, Salwa S. Zghebi, Anan Bader Eddeen, Peter P. Liu, Douglas S. Lee, Karen Tu, Sheldon W. Tobe, Evangelos Kontopantelis, Mamas A. Mamas · 2022 · Diabetes Care
68. Combined treatment with sacubitril/valsartan plus dapagliflozin in patients affected by heart failure with reduced ejection fraction
    Juan Jiang, Jie Gao, Xiuzhen Zhang, Yuanmin Li, Heqin Dang, Yanlin Liu, Wenwen Chen · 2023 · Frontiers in Cardiovascular Medicine
69. Uptake of SGLT2i and Outcomes in Patients with Diabetes and Heart Failure: A Population-Based Cohort and a Specialized Clinic Cohort
    Luke R. Gagnon, Deepan Hazra, Kevin Perera, Kaiming Wang, Niharika Kashyap, Chandu Sadasivan, Erik R. E. Youngson, Luan Manh Chu, Douglas C. Dover, Padma Kaul et al. · 2024 · American Heart Journal
70. Echocardiographic and biomarker characteristics in diabetes, coronary artery disease or both: insights from HOMAGE trial
    Luca Monzo, Masatake Kobayashi, João Pedro Ferreira, Zohra Lamiral, Christian Delles, Andrew L. Clark, Frank Edelmann, Arantxa González, Stephane R B Heymans, Pierpaolo Pellicori et al. · 2025 · Cardiovascular Diabetology
71. What Makes Sodium-Glucose Co-Transporter-2 Inhibitors Stand out in Heart Failure?
    Muhammad Shahzeb Khan, Muthiah Vaduganathan · 2020 · Current Diabetes Reports
72. National Asthma Education and Prevention Program 2020 Guidelines: What’s Important for Primary Care
    Murphy Murphy · 2021 · The Journal of Family Practice
73. Effect of canagliflozin on N-terminal pro-brain natriuretic peptide in patients with type 2 diabetes and chronic heart failure according to baseline use of glucose-lowering agents
    Atsushi Tanaka, Shigeru Toyoda, Takumi Imai, Kazuki Shiina, Hirofumi Tomiyama, Yasushi Matsuzawa, Takahiro Okumura, Yumiko Kanzaki, Katsuya Onishi, Arihiro Kiyosue et al. · 2021 · Cardiovascular Diabetology
74. Estrés oxidativo mitocondrial y envejecimiento cardíaco
    Beatriz Martín‐Fernández, Ricardo Gredilla · 2018 · Clínica e Investigación en Arteriosclerosis
75. Clinical impact of oral antidiabetic medications in heart failure patients
    Alberto Palazzuoli, Elena Ceccarelli, Gaetano M. Ruocco, Ranuccio Nuti · 2018 · Heart Failure Reviews
76. Prognostic Impact of Fasting Plasma Glucose on Mortality and Re-Hospitalization in Patients with Acute Heart Failure
    Yu-Yang Chen, Yuan Chen, Shu-Min Liang, Zi-Zhuo Su, Xiaorong Shu, Hai-Feng Zhang, Siu‐Hin Wan, Jing-Feng Wang, Shuang-Lun Xie · 2018 · Chinese Medical Journal
77. Elevated 1-h post-load plasma glucose is associated with right ventricular morphofunctional parameters in hypertensive patients
    Angela Sciacqua, Maria Perticone, Sofia Miceli, Angelina Pinto, Velia Cassano, Elena Succurro, Francesco Andreozzi, Marta Letizia Hribal, Giorgio Sesti, Francesco Perticone · 2019 · Endocrine
78. Mechanisms underlying diabetic cardiomyopathy: From pathophysiology to novel therapeutic targets.
    Shuo Cong, Chrishan J. A. Ramachandra, K.P. Myu Mai Ja, Jonathan Yap, WINSTON S. N. SHIM, Lai Wei, Derek John Hausenloy · 2020 · PubMed
79. Impact of diabetes and on-arrival hyperglycemia on short-term outcomes in acute heart failure patients
    Josep Masip, Marina Povar-Echeverría, W. Frank Peacock, Javier Jacob, Víctor Gil, Pablo Herrero, Pere Llorens, Aitor Alquézar‐Arbé, Carolina Sánchez, Francisco Javier Martín‐Sánchez et al. · 2022 · Internal and Emergency Medicine
80. Echocardiographic Myocardial Work: A Novel Method to Assess Left Ventricular Function in Patients with Coronary Artery Disease and Diabetes Mellitus
    Alexandra-Cătălina Frișan, Cristian Mornoş, Mihai-Andrei Lazăr, Raluca Șoșdean, Simina Crișan, Ioana Ionac, Constantin Tudor Luca · 2024 · Medicina
81. Impact of sarcopenic obesity on heart failure in people with type 2 diabetes and the role of metabolism and inflammation: A prospective cohort study
    Xueqing Jia, Liming Zhang, Zhenqing Yang, Xingqi Cao, Yao Zhao, Jingyun Zhang, Zuobing Chen, Zuyun Liu · 2024 · Diabetes & Metabolic Syndrome Clinical Research & Reviews
82. Cardiac digital twins: a tool to investigate the function and treatment of the diabetic heart
    Marina Strocchi, Daniel J. Hammersley, Brian P. Halliday, Sanjay Kumar Prasad, Steven Niederer · 2025 · Cardiovascular Diabetology
83. Observational study investigating the prevalence of asymptomatic stage B heart failure in patients with type 2 diabetes who are not known to have coronary artery disease
    Mon Myat Oo, Isaiah Tan Chung Zhen, Kee Seong Ng, Kok Leng Tan, Alexander Tong Boon Tan, Shireene Ratna Vethakkan, Jeyakantha Ratnasingam, Kok Han Chee · 2021 · BMJ Open
84. HbA1c level is associated with the development of heart failure with recovered ejection fraction in hospitalized heart failure patients with type 2 diabetes
    Chen Die Yang, Muladili Aihemaiti, Jin Wei Quan, Jia Wei Chen, Xin Yi Shu, Feng Hua Ding, Wei Feng Shen, Lin Lu, Ruiyan Zhang, Wen Qi Pan et al. · 2022 · International Journal of Cardiology
85. Practical approaches for the treatment of chronic heart failure: Frequently asked questions, overlooked points and controversial issues in current clinical practice
    Yüksel Çavuşoğlu, Hakan Altay, Ahmet Ekmekçi, Mehmet Eren, Mehmet Serdar Küçükoğlu, Sanem Nalbantgil, İbrahim Sarı, Timur Selçuk, Ahmet Temizhan, Dilek Ural et al. · 2015 · The Anatolian Journal of Cardiology
86. Mitochondrial oxidative stress and cardiac ageing
    Beatriz Martín‐Fernández, Ricardo Gredilla · 2018 · Clínica e Investigación en Arteriosclerosis (English Edition)
87. The cholesterol paradox may be attenuated in heart failure patients with diabetes
    Filipe Manuel Cunha, Joana Certo Pereira, Ana Ribeiro, Sérgio Silva, José Paulo Araújo, Adelino Ferreira Leite-Moreira, Paulo Bettencourt, Patrícia Lourenço · 2020 · Minerva Medica
88. Development and Validation of a Nomogram Model for Predicting the Risk of Readmission in Patients with Heart Failure with Reduced Ejection Fraction within 1 Year
    Yue Hu, Xiaotong Wang, Shengjue Xiao, Chunyan Huan, Huimin Wu, Tao Xu, Minjia Guo, Hong Zhu, Defeng Pan · 2022 · Cardiovascular Therapeutics
89. Anti-Diabetic Therapy and Heart Failure: Recent Advances in Clinical Evidence and Molecular Mechanism
    Chih‐Neng Hsu, Chin‐Feng Hsuan, Daniel Liao, Jack. Keng-Jui Chang, Allen Jiun-Wei Chang, Siow‐Wey Hee, Hsiao-Lin Lee, Sean I. F. Teng · 2023 · Life
90. Risk of heart failure with dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes mellitus: A meta-analysis of randomized controlled trials
    Amartya Kundu, Partha Sardar, Sreeparna Ghosh, Parth B. Patel, Saurav Chatterjee, Theo E. Meyer · 2016 · International Journal of Cardiology
91. Exploring SGLT-2 Inhibitors: Benefits beyond the Glucose-Lowering Effect—What Is New in 2023?
    Clipper F. Young, Neeka Farnoudi, Jenny Chen, Jay H. Shubrook · 2023 · Endocrines
92. Prognostic implications of fasting plasma glucose in subjects with echocardiographic abnormalities
    Manan Pareek, Muthiah Vaduganathan, Deepak L. Bhatt, Margrét Leósdóttir, Michael Hecht Olsen · 2017 · International Journal of Cardiology
93. Effect of multimorbidity on survival of patients diagnosed with heart failure: a retrospective cohort study in Singapore
    Palvinder Kaur, Nakul Saxena, Alex Xiaobin You, Raymond Ching-Chiew Wong, Choon Pin Lim, Seet Yoong Loh, Pradeep Paul George · 2018 · BMJ Open
94. Diabetes and Heart Failure
    Adi Mehta, Sanjeeb Bhattacharya, Jerry D. Estep, Charles Faiman · 2020 · Clinics in Geriatric Medicine
95. Clinical Considerations for Use of SGLT2 Inhibitor Therapy in Patients with Heart Failure and Reduced Ejection Fraction: A Review
    Nisha B. Jhalani · 2022 · Advances in Therapy
96. Empagliflozin across the stages of diabetic heart disease
    Francesco Paneni · 2017 · European Heart Journal
97. Impact of Diabetes and Glycemia on Cardiac Improvement and Adverse Events Following Mechanical Circulatory Support
    Christos P. Kyriakopoulos, Iosif Taleb, Eleni Tseliou, Konstantinos Sideris, Rana Hamouche, Eleni Maneta, Marisca Nelson, Ethan Krauspe, Sean Selko, Joseph R. Visker et al. · 2024 · Journal of the American Heart Association
98. microRNAs in ischaemic cardiovascular diseases
    Simona Greco, Germana Zaccagnini, Christine Voellenkle, Fabio Martelli · 2016 · European Heart Journal Supplements
99. Assessing risk of future cardiovascular events, healthcare resource utilization and costs in patients with type 2 diabetes, prior cardiovascular disease and both
    Chi Nguyen, Rakesh Luthra, Effie L. Kuti, Vincent J. Willey · 2020 · Current Medical Research and Opinion
100. Glucose dysregulation and subclinical cardiac dysfunction in older adults: The Cardiovascular Health Study
     Parveen K. Garg, Mary L. Biggs, Jorge R. Kizer, Sanjiv Jayendra Shah, Bruce M. Psaty, Mercedes R. Carnethon, John S. Gottdiener, David S. Siscovick, Kenneth Jay Mukamal · 2022 · Cardiovascular Diabetology